Covered recipient · General Payments record
REBECCA MARGARET SHEPHERD
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2019
$536.74
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.23 | 16 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $161.20 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.38 | 2 |
| UCB, Inc. | $20.92 | 1 |
| Janssen Biotech, Inc. | $18.73 | 1 |
| Celgene Corporation | $17.68 | 1 |
| GlaxoSmithKline, LLC. | $16.56 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.91 | 1 |
| PFIZER INC. | $13.43 | 1 |
| Lilly USA, LLC | $11.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $5.03 | 02/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911501 | CMS |
| Amgen Inc. | $16.35 | 02/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911511 | CMS |
| Amgen Inc. | $3.62 | 02/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911505 | CMS |
| Amgen Inc. | $5.37 | 05/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911507 | CMS |
| Amgen Inc. | $11.50 | 06/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911497 | CMS |
| Amgen Inc. | $16.41 | 06/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911513 | CMS |
| Amgen Inc. | $102.92 | 09/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662911517 | CMS |
| Celgene Corporation | $17.68 | 05/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672811599 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.91 | 06/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 651416605 | CMS |
| GlaxoSmithKline, LLC. | $16.56 | 04/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671553813 | CMS |
| Janssen Biotech, Inc. | $18.73 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658712301 | CMS |
| Lilly USA, LLC | $11.42 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658096859 | CMS |
| Novartis Pharmaceuticals Corporation | $22.55 | 01/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 660157729 | CMS |
| Novartis Pharmaceuticals Corporation | $11.83 | 09/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 660157733 | CMS |
| PFIZER INC. | $13.43 | 05/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672245591 | CMS |
| UCB, Inc. | $20.92 | 03/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 688381357 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.